However, a consensus from the National Kidney Foundation defined ‘adequate’ 25(OH)D concentrations in CKD stages 3–4 as >20 ng/mL, assuming the absence of a counter-elevation in PTH levels, and agreed that 25(OH)D concentrations < 15 ng/mL should be corrected regardless of PTH level [32]. Here, PTH is linked to chronic kidney disease.